The CBIS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CBIS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CBIS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CBIS Detailed Price Forecast - CNN Money||View CBIS Detailed Summary - Google Finance|
|View CBIS Detailed Summary - Yahoo! Finance||View CBIS Stock Research & Analysis - Zacks.com|
|View CBIS Trends & Analysis - Trade-Ideas||View CBIS Major Holders - Barrons|
|View CBIS Call Transcripts - NASDAQ||View CBIS Breaking News & Analysis - Seeking Alpha|
|View CBIS Annual Report - CompanySpotlight.com||View CBIS OTC Short Report - OTCShortReport.com|
|View CBIS Fundamentals - TradeKing||View CBIS SEC Filings - Bar Chart|
|View Historical Prices for CBIS - The WSJ||View Performance/Total Return for CBIS - Morningstar|
|View the Analyst Estimates for CBIS - MarketWatch||View the Earnings History for CBIS - CNBC|
|View the CBIS Earnings - StockMarketWatch||View CBIS Buy or Sell Recommendations - MacroAxis|
|View the CBIS Bullish Patterns - American Bulls||View CBIS Short Pain Metrics - ShortPainBot.com|
|View CBIS Stock Mentions - StockTwits||View CBIS Stock Mentions - PennyStockTweets|
|View CBIS Stock Mentions - Twitter||View CBIS Investment Forum News - Investor Hub|
|View CBIS Stock Mentions - Yahoo! Message Board||View CBIS Stock Mentions - Seeking Alpha|
|View Insider Transactions for CBIS - SECform4.com||View Insider Transactions for CBIS - Insider Cow|
|View CBIS Major Holdings Summary - CNBC||View Insider Disclosure for CBIS - OTC Markets|
|View Insider Transactions for CBIS - Yahoo! Finance||View Institutional Holdings for CBIS - NASDAQ|
|View CBIS Stock Insight & Charts - FinViz.com||View CBIS Investment Charts - StockCharts.com|
|View CBIS Stock Overview & Charts - BarChart||View CBIS User Generated Charts - Trading View|
Independent Valuation of U.S. Patent Number 9,763,991 for Cannabinol (CBN) Initiated as Cannabis Science Negotiates Licensing and Marketing Deals in Canada and the USA to Develop and Sell CBN Products Utilizing the Company’s Patent
Posted on Monday April 15, 2019
IRVINE, CA, April 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that it is in current negotiations to license the Company’s U.S. patent number 9,763,991 for the Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, including Anxiety, Sleep Disorders, PTSD and more. The U.S. market for sleep disorder products alone was estimated at over $28 billion in 2017 and is expected to grow by 3.3% annually.
Elpasso Farms Just Announced South African Health Products Regulatory Authority (SAHPRA) Awarded Elpasso Farms One of the First Medical Cannabis Cultivation Licenses; Cannabis Science Applauds
Posted on Wednesday April 10, 2019
“Together with Cannabis Science, we have the opportunity to take a leadership position in the medical cannabis industry in South Africa and develop medicines that can help millions of people throughout Africa. We are one of the few companies to qualify for a medical cannabis license in South Africa. Elpasso Farms is positioned to commence the cultivation of medical cannabis to support the Company’s research and development initiatives that are currently underway in South Africa, North America, Europe, and other international jurisdictions.
Cannabis Science Expands Into Canadian Market With Wholly-Owned Subsidiary Cannabis Science Canada Inc., Commences Negotiations for Canadian Land, Licenses, and Expansion Capital
Posted on Monday March 25, 2019
IRVINE, CA, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has expanded into the Canadian market with the formation of Cannabis Science Canada, Inc. Cannabis Science Canada Inc. is a wholly-owned subsidiary of Cannabis Science Inc., and has already begun negotiations for Canadian land, licenses, and expansion capital. “We currently have a number of very important research and drug-development initiatives underway in the U.S., Europe, South America, and in Sub-Saharan Africa.
Cannabis Science iCannabinoid Ambassadors Program Appointments Underway; Ambassadors Will Promote Company Initiatives Globally and Help Share Accurate and Reliable Health Information
Posted on Friday March 15, 2019
IRVINE, CA, March 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that today it has launched the selection and appointment process for the Company’s iCannabinoid Ambassador’s Program. One of the most important components of Cannabis Science’s growth and international market penetration strategy is information and the power of the people! The iCannabinoid Ambassador’s Program is expected to help Cannabis Science rapidly expand the Company’s footprint and support the development of new initiatives in new markets. Each iCannabinoid Ambassador will be designated an area of interest and expertise, based on your experience, expertise, and desired level of commitment.